Debt-to-equity of Kraig Biocraft Laboratories, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Kraig Biocraft Laboratories, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Kraig Biocraft Laboratories, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -121%, a 13% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Kraig Biocraft Laboratories, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -121% +18% +13% 30 Sep 2025
Q2 2025 -120% +29% +20% 30 Jun 2025
Q1 2025 -123% +40% +24% 31 Mar 2025
Q4 2024 -130% +48% +27% 31 Dec 2024
Q3 2024 -139% +56% +29% 30 Sep 2024
Q2 2024 -150% +61% +29% 30 Jun 2024
Q1 2024 -163% +64% +28% 31 Mar 2024
Q4 2023 -177% +52% +23% 31 Dec 2023
Q3 2023 -195% +11% +5.6% 30 Sep 2023
Q2 2023 -211% -25% -13% 30 Jun 2023
Q1 2023 -227% -53% -30% 31 Mar 2023
Q4 2022 -229% -78% -52% 31 Dec 2022
Q3 2022 -206% -65% -46% 30 Sep 2022
Q2 2022 -186% -57% -45% 30 Jun 2022
Q1 2022 -174% -60% -53% 31 Mar 2022
Q4 2021 -151% -39% -35% 31 Dec 2021
Q3 2021 -141% -31% -28% 30 Sep 2021
Q2 2021 -129% -16% -14% 30 Jun 2021
Q1 2021 -114% +3.6% +3.1% 31 Mar 2021
Q4 2020 -112% +11% +9% 31 Dec 2020
Q3 2020 -110% +9.8% +8.2% 30 Sep 2020
Q2 2020 -113% 30 Jun 2020
Q1 2020 -118% 31 Mar 2020
Q4 2019 -123% 31 Dec 2019
Q3 2019 -120% 30 Sep 2019
Q2 2017 -114% 30 Jun 2017
Q1 2017 -113% 31 Mar 2017
Q4 2016 -113% 31 Dec 2016
Q3 2016 -113% 30 Sep 2016
Q4 2013 -116% +7% +5.7% 31 Dec 2013
Q3 2013 -111% +17% +13% 30 Sep 2013
Q2 2013 -111% +17% +13% 30 Jun 2013
Q1 2013 -117% +5.4% +4.4% 31 Mar 2013
Q4 2012 -123% 31 Dec 2012
Q3 2012 -128% 30 Sep 2012
Q2 2012 -128% 30 Jun 2012
Q1 2012 -122% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.